| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 39,980 | $30 | $1.4M |
| J3262 | Injection, tocilizumab, 1 mg | 88,400 | $10 | $442K |
| J2357 | Injection, omalizumab, 5 mg | 10,380 | $30 | $311.4K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 10,130 | $30 | $263.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,700 | $90 | $254.1K |
| J0897 | Injection, denosumab, 1 mg | 8,580 | $20 | $163K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 11,950 | $10 | $131.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 790 | $100 | $78.9K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 1,890 | $20 | $41.6K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 160 | $160 | $25.4K |